Developer docs
API playgroundTry for free, no card

Search company profiles

SIRO Clinpharm

Full company profile

uuid000ayop

Namestring
SIRO Clinpharm
Legal namestring
SIRO Clinpharm Private Limited
Company typeenum
Private
Founded yearint
1996
Descriptiontext

SIRO Clinpharm Private Limited is a Mumbai-headquartered clinical research organization (CRO) founded in 1996 as the SIRO Research Foundation and incorporated in 2000. The company delivers drug development and discovery solutions to global pharmaceutical, biotechnology, medical device, and academic institutions, operating through three wholly-owned specialized verticals: SIRO Clintech (full-service CRO offering study design, site management, data management, biostatistics, medical writing, and clinical trial supplies management), SIRO Medical Writing (regulatory filings, safety reports, scientific publications), and SIRO Functional Services (FSP workforce solutions).

The company's core offering is its Functional Service Provider (FSP) model, which provides flexible workforce augmentation through staff augmentation, managed staffing, and hybrid engagement models, with FTE-based pricing. SIRO operates a suite of web-based clinical trial applications including EDC (Electronic Data Capture), CTMS (Clinical Trial Management System), IWRS (Interactive Web Response System), and e-Diary for patient-reported outcomes. Through a strategic partner network, SIRO maintains the ability to hire and employ resources across 150+ countries, addressing multinational trial staffing and local regulatory compliance requirements for global sponsors.

SIRO is founder-controlled, with Akshay Daftary and Karan Daftary serving as Managing Directors and Gautam Daftary as Chairman. The company raised approximately $30.5M across two PE rounds in 2006-2007 from Baring Private Equity India, 3i Group, and Kotak Private Equity. It has 251-500 employees and recently secured SBTi approval for 42% Scope 1/2 emissions reduction by 2030. The GTM motion is direct enterprise sales via RFI/RFP processes targeting large multinational sponsors.

Short descriptiontext

SIRO Clinpharm is a Mumbai-based CRO offering FSP workforce solutions and full-service clinical development across three specialized verticals, serving global pharma, biotech, medical device, and academic clients in 150+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersThane, India
HQ citystring
Thane
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract research organization, clinical research services, functional service provider, medical writing services, pharmacovigilance services
Industry4 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAM
Functional Service Providers (FSP) & Resourcing CROs
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization (CRO) Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Functional Service Provider (FSP) Solutions
TypeManaged Services
Description

SIRO provides flexible FSP solutions allowing clients to augment their teams with specialized resources for clinical trial functions. Services include staff augmentation (FTE-based model), managed staffing, and hybrid models. Revenue is generated through FTE (full-time equivalent) based pricing models with flexible deployment options.

siroclinpharm.com
2Full-Service CRO Services (SIRO Clintech)
TypeProfessional Services
Description

Through its subsidiary SIRO Clintech, the company offers full-service clinical development services including study design, site management, data management, biostatistics, medical writing, and clinical trial supplies management.

siroclinpharm.com
3Medical Writing Services (SIRO Medical Writing)
TypeProfessional Services
Description

Best-in-class medical writing services supporting drug development from regulatory filings and safety reports to scientific publications, delivered through the specialized SIRO Medical Writing subsidiary.

siroclinpharm.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SIRO Clinpharm is a Contract Research Organization (CRO) that delivers clinical research and drug development solutions through three specialized verticals: SIRO Clinpharm's Functional Service Provider (FSP) solutions (staff augmentation, managed staffing, and hybrid models), SIRO Clintech's full-service clinical development offerings (study design, site management, data management, biostatistics, and clinical trial supplies), and SIRO Medical Writing's regulatory and scientific documentation services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

SIRO Clinpharm is a Contract Research Organization (CRO) offering a multi-product portfolio organized into three specialized vertical companies under the SIRO Group umbrella. The core offering is SIRO Clinpharm's Functional Service Provider (FSP) services, which deliver flexible workforce solutions for clinical trial operations including staff augmentation, managed staffing, and hybrid engagement models with global reach across 150+ countries. This is complemented by SIRO Clintech, a full-service CRO providing end-to-end clinical development services from study design through data management and biostatistics. SIRO Medical Writing provides specialized regulatory and scientific documentation services. Together, these three verticals serve global biotech, pharmaceutical, medical device, and academic institutions across the drug development lifecycle.

Product and service3 records
1SIRO Clinpharm FSP Services
CategoryFunctional Service Provider
Description

Functional Service Provider (FSP) solutions providing flexible workforce augmentation for clinical trial functions. Includes staff augmentation (FTE-based, on-site or remote resources under client supervision), FSP managed staffing (SIRO provides functional oversight, hiring and line management), and hybrid models combining FTE and FSO approaches. Enables global deployment across 150+ countries with quick resource scaling.

2SIRO Clintech Full-Service CRO
CategoryFull-Service CRO
Description

Full-service Contract Research Organization offering a complete spectrum of clinical development services including study design, site management, clinical monitoring, data management, biostatistics and statistical programming, medical writing, and clinical trial supplies management. Delivered by wholly-owned subsidiary SIRO Clintech Private Limited for global pharma, biotech, medical device and academic clients.

3SIRO Medical Writing
CategoryMedical Writing Services
Description

Medical writing services supporting drug development from initial regulatory filings and safety reports to impactful scientific publications. Expertise spans the entire value chain of clinical documentation. Delivered by wholly-owned subsidiary SIRO Medical Writing Private Limited.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Strategic Partner Network
Strategic tierCoreTypeOthers
Description

SIRO collaborates with strategic partners to provide resources in 150+ countries where clients may not have representation or where local regulatory compliance is difficult. The partnership enables SIRO to hire and employ across 150+ countries, extending global reach for clinical trial operations.

siroclinpharm.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

IQVIA is the world's largest CRO and life sciences services firm, offering full-service clinical development, FSP/resourcing, and technology platforms (EDC, CTMS). It competes with SIRO on enterprise pharma RFPs and FSP engagements globally, but at vastly greater scale.

TypeBroad incumbent
Description

ICON is a top-tier global CRO offering full-service clinical development, FSP via ICON Functional Services, and biostatistics/data management. It is the most direct large incumbent comparable to SIRO's combined full-service CRO + FSP + biostatistics offering.

TypeBroad incumbent
Description

Fortrea, spun out from Labcorp, is a global CRO providing clinical development, FSP/resourcing, and central lab services. Comparable to SIRO's full-service CRO and FSP verticals, with much larger geographic reach and central lab capabilities SIRO lacks.

TypeBroad incumbent
Description

Parexel is a global CRO (now private-equity owned by EQT/Goldman) offering full-service clinical development, biostatistics, regulatory, and FSP solutions. Comparable across the same service lines as SIRO's three verticals, though at significantly larger scale and global footprint.

TypeBroad incumbent
Description

Syneos Health is a global clinical and commercial solutions provider offering full-service CRO, FSP, biostatistics, and medical writing. Direct overlap with SIRO's portfolio across all three verticals; recently taken private by Elliott/Veritas, indicating a comparable roll-up trajectory.

TypeDirect peer
Description

Medpace is a mid-to-large global CRO focused on full-service clinical development across multiple therapeutic areas. Comparable to SIRO Clintech's full-service CRO offering, though Medpace operates at significantly larger scale with proprietary technology and a US-centric delivery model.

TypeBroad incumbent
Description

Charles River is a global CRO/CDMO with clinical development services, FSP, and safety/pharmacovigilance offerings. Comparable to SIRO across CRO and FSP, with additional discovery/manufacturing capabilities and global lab footprint.

TypeDirect peer
Description

Worldwide Clinical Trials is a mid-sized global CRO offering full-service clinical development, biostatistics, data management, and medical writing. Closely comparable to SIRO in scale and service mix, especially the SIRO Clintech and SIRO Medical Writing verticals.

TypeDirect peer
Description

Novotech is an Asia-Pacific-focused mid-sized CRO offering full-service clinical development with strong India and regional delivery. Highly comparable to SIRO in geographic positioning, India-based delivery, and mid-tier CRO scale.

TypeEmerging player
Description

CliniOps is a digital clinical trials platform and FSP provider with India-based operations, focused on decentralized trials and clinical data services. Comparable to SIRO's FSP and data management capabilities, with a more technology-forward positioning.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SIRO Clinpharm

Contract Research Organization (CRO) Servicessiroclinpharm.com

SIRO Clinpharm is a Mumbai-based CRO offering FSP workforce solutions and full-service clinical development across three specialized verticals, serving global pharma, biotech, medical device, and academic clients in 150+ countries.

What SIRO Clinpharm does

SIRO Clinpharm Private Limited is a Mumbai-headquartered clinical research organization (CRO) founded in 1996 as the SIRO Research Foundation and incorporated in 2000. The company delivers drug development and discovery solutions to global pharmaceutical, biotechnology, medical device, and academic institutions, operating through three wholly-owned specialized verticals: SIRO Clintech (full-service CRO offering study design, site management, data management, biostatistics, medical writing, and clinical trial supplies management), SIRO Medical Writing (regulatory filings, safety reports, scientific publications), and SIRO Functional Services (FSP workforce solutions).

The company's core offering is its Functional Service Provider (FSP) model, which provides flexible workforce augmentation through staff augmentation, managed staffing, and hybrid engagement models, with FTE-based pricing. SIRO operates a suite of web-based clinical trial applications including EDC (Electronic Data Capture), CTMS (Clinical Trial Management System), IWRS (Interactive Web Response System), and e-Diary for patient-reported outcomes. Through a strategic partner network, SIRO maintains the ability to hire and employ resources across 150+ countries, addressing multinational trial staffing and local regulatory compliance requirements for global sponsors.

SIRO is founder-controlled, with Akshay Daftary and Karan Daftary serving as Managing Directors and Gautam Daftary as Chairman. The company raised approximately $30.5M across two PE rounds in 2006-2007 from Baring Private Equity India, 3i Group, and Kotak Private Equity. It has 251-500 employees and recently secured SBTi approval for 42% Scope 1/2 emissions reduction by 2030. The GTM motion is direct enterprise sales via RFI/RFP processes targeting large multinational sponsors.

SIRO Clinpharm firmographics

Firmographics
Name
SIRO Clinpharm
Legal name
SIRO Clinpharm Private Limited
Website
https://siroclinpharm.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
251–500 employees
Short description
SIRO Clinpharm is a Mumbai-based CRO offering FSP workforce solutions and full-service clinical development across three specialized verticals, serving global pharma, biotech, medical device, and academic clients in 150+ countries.
Ownership category
akta.pro rank

SIRO Clinpharm industry classification

Industry
Product category
Contract Research Organization (CRO) Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAM
Functional Service Providers (FSP) & Resourcing CROs
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs

Keywords

  • Contract research organization
  • Clinical research services
  • Functional service provider
  • Medical writing services
  • Pharmacovigilance services

Where SIRO Clinpharm is headquartered

Location

Headquarters

HQ city
Thane
HQ country
India
HQ region
Asia

Offices1 record

Markets served

SIRO Clinpharm business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Functional Service Provider (FSP) Solutions: SIRO provides flexible FSP solutions allowing clients to augment their teams with specialized resources for clinical trial functions. Services include staff augmentation (FTE-based model), managed staffing, and hybrid models. Revenue is generated through FTE (full-time equivalent) based pricing models with flexible deployment options.
  2. Full-Service CRO Services (SIRO Clintech): Through its subsidiary SIRO Clintech, the company offers full-service clinical development services including study design, site management, data management, biostatistics, medical writing, and clinical trial supplies management.
  3. Medical Writing Services (SIRO Medical Writing): Best-in-class medical writing services supporting drug development from regulatory filings and safety reports to scientific publications, delivered through the specialized SIRO Medical Writing subsidiary.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

SIRO Clinpharm product offering

Product offering

Core offering

SIRO Clinpharm is a Contract Research Organization (CRO) that delivers clinical research and drug development solutions through three specialized verticals: SIRO Clinpharm's Functional Service Provider (FSP) solutions (staff augmentation, managed staffing, and hybrid models), SIRO Clintech's full-service clinical development offerings (study design, site management, data management, biostatistics, and clinical trial supplies), and SIRO Medical Writing's regulatory and scientific documentation services.

Product overview

SIRO Clinpharm is a Contract Research Organization (CRO) offering a multi-product portfolio organized into three specialized vertical companies under the SIRO Group umbrella. The core offering is SIRO Clinpharm's Functional Service Provider (FSP) services, which deliver flexible workforce solutions for clinical trial operations including staff augmentation, managed staffing, and hybrid engagement models with global reach across 150+ countries. This is complemented by SIRO Clintech, a full-service CRO providing end-to-end clinical development services from study design through data management and biostatistics. SIRO Medical Writing provides specialized regulatory and scientific documentation services. Together, these three verticals serve global biotech, pharmaceutical, medical device, and academic institutions across the drug development lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

  • SIRO Clinpharm FSP Services Functional Service Provider (FSP) solutions providing flexible workforce augmentation for clinical trial functions. Includes staff augmentation (FTE-based, on-site or remote resources under client supervision), FSP managed staffing (SIRO provides functional oversight, hiring and line management), and hybrid models combining FTE and FSO approaches. Enables global deployment across 150+ countries with quick resource scaling.
  • SIRO Clintech Full-Service CRO Full-service Contract Research Organization offering a complete spectrum of clinical development services including study design, site management, clinical monitoring, data management, biostatistics and statistical programming, medical writing, and clinical trial supplies management. Delivered by wholly-owned subsidiary SIRO Clintech Private Limited for global pharma, biotech, medical device and academic clients.
  • SIRO Medical Writing Medical writing services supporting drug development from initial regulatory filings and safety reports to impactful scientific publications. Expertise spans the entire value chain of clinical documentation. Delivered by wholly-owned subsidiary SIRO Medical Writing Private Limited.

Companies that use SIRO Clinpharm

Customer profile

Segments4 records

Ideal customer profiles3 records

SIRO Clinpharm technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

SIRO Clinpharm partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Strategic Partner NetworkcoreOthersSIRO collaborates with strategic partners to provide resources in 150+ countries where clients may not have representation or where local regulatory compliance is difficult. The partnership enables SIRO to hire and employ across 150+ countries, extending global reach for clinical trial operations.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

SIRO Clinpharm competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA is the world's largest CRO and life sciences services firm, offering full-service clinical development, FSP/resourcing, and technology platforms (EDC, CTMS). It competes with SIRO on enterprise pharma RFPs and FSP engagements globally, but at vastly greater scale.
  • ICON plc: ICON is a top-tier global CRO offering full-service clinical development, FSP via ICON Functional Services, and biostatistics/data management. It is the most direct large incumbent comparable to SIRO's combined full-service CRO + FSP + biostatistics offering.
  • Labcorp Drug Development (Fortrea): Fortrea, spun out from Labcorp, is a global CRO providing clinical development, FSP/resourcing, and central lab services. Comparable to SIRO's full-service CRO and FSP verticals, with much larger geographic reach and central lab capabilities SIRO lacks.
  • Parexel International: Parexel is a global CRO (now private-equity owned by EQT/Goldman) offering full-service clinical development, biostatistics, regulatory, and FSP solutions. Comparable across the same service lines as SIRO's three verticals, though at significantly larger scale and global footprint.
  • Syneos Health: Syneos Health is a global clinical and commercial solutions provider offering full-service CRO, FSP, biostatistics, and medical writing. Direct overlap with SIRO's portfolio across all three verticals; recently taken private by Elliott/Veritas, indicating a comparable roll-up trajectory.
  • Charles River Laboratories: Charles River is a global CRO/CDMO with clinical development services, FSP, and safety/pharmacovigilance offerings. Comparable to SIRO across CRO and FSP, with additional discovery/manufacturing capabilities and global lab footprint.

Direct peers

  • Medpace Holdings: Medpace is a mid-to-large global CRO focused on full-service clinical development across multiple therapeutic areas. Comparable to SIRO Clintech's full-service CRO offering, though Medpace operates at significantly larger scale with proprietary technology and a US-centric delivery model.
  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO offering full-service clinical development, biostatistics, data management, and medical writing. Closely comparable to SIRO in scale and service mix, especially the SIRO Clintech and SIRO Medical Writing verticals.
  • Novotech: Novotech is an Asia-Pacific-focused mid-sized CRO offering full-service clinical development with strong India and regional delivery. Highly comparable to SIRO in geographic positioning, India-based delivery, and mid-tier CRO scale.

Emerging players

  • CliniOps: CliniOps is a digital clinical trials platform and FSP provider with India-based operations, focused on decentralized trials and clinical data services. Comparable to SIRO's FSP and data management capabilities, with a more technology-forward positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

SIRO Clinpharm social profiles

Digital presence

SIRO Clinpharm compliance and trust

Trust signal

Compliance1 record

SIRO Clinpharm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SIRO Clinpharm leadership team

Management profile

Number of profiles

Profiles5 records

SIRO Clinpharm subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

SIRO Clinpharm funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SIRO Clinpharm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SIRO Clinpharm

What does SIRO Clinpharm do?

SIRO Clinpharm is a Contract Research Organization (CRO) that delivers clinical research and drug development solutions through three specialized verticals: SIRO Clinpharm's Functional Service Provider (FSP) solutions (staff augmentation, managed staffing, and hybrid models), SIRO Clintech's full-service clinical development offerings (study design, site management, data management, biostatistics, and clinical trial supplies), and SIRO Medical Writing's regulatory and scientific documentation services.

Is SIRO Clinpharm a public or private company?

SIRO Clinpharm is a private company. It is classified as family owned and is currently operating.

When was SIRO Clinpharm founded?

SIRO Clinpharm was founded in 1996. It employs 251 to 500 people.

Where is SIRO Clinpharm based?

SIRO Clinpharm is headquartered in Thane, India, in the Asia region.

How does SIRO Clinpharm make money?

Three revenue lines are on record. Functional Service Provider (FSP) Solutions are the primary driver. The others are full-Service CRO Services (SIRO Clintech) and medical Writing Services (SIRO Medical Writing).

Who are SIRO Clinpharm's main competitors?

Broad incumbents on record are IQVIA, ICON plc, Labcorp Drug Development (Fortrea), Parexel International, Syneos Health and Charles River Laboratories. Direct peers are Medpace Holdings, Worldwide Clinical Trials and Novotech. CliniOps is listed as an emerging player.

Does SIRO Clinpharm have an API?

No public API is recorded for SIRO Clinpharm.

What industry is SIRO Clinpharm in?

SIRO Clinpharm's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAM, Functional Service Providers (FSP) & Resourcing CROs. Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals